İnfantil Başlangıçlı Bir Tip 2 Glikojen Depo Hastalığı: Olgu Sunumu

Yıl 2014, Cilt: 12 Sayı: 2, 131 - 134, 01.09.2014

Serkan Bilge Koca Emine Polat Bahtışen Bayram Gizem Ürel Saliha Şenel İlyas Okur

https://doi.org/10.4274/jcp.87487

Öz

Glikojen depo hastalığı tip 2 Pompe hastalığı hipotoni ve kas güçsüzlüğü ile seyreden otozomal resesif geçişli fatal bir glikojen depo hastalığıdır. Lizozomal asit alfa-glikozidaz asit maltaz enziminin eksikliğinin ilerleyici jeneralize miyopati, kardiyomiyopati ve solunum kasları güçsüzlüğü nedeniyle erken süt çocukluğu döneminde ölüme yol açtığı bilinmektedir. Hastalığın patogenezinde hücreler içinde yıkılamayan aşırı glikojen birikimi rol oynar. Bu yazıda 3,5 aylık pnömoni ve hipotoninin yol açtığı solunum yetmezliği ile başvuran, daha sonra Pompe hastalığı tanısı alan hasta sunuldu

Anahtar Kelimeler

Pompe hastalığı, süt çocukluğu, hipotoni

Infantile Onset Glycogen Storage Disease Type 2: Case Report

Öz

Glycogen storage disease type 2 Pompe’s disease is an autosomal recessive, fatal glycogen storage disease presenting with hypotonia and muscle weakness. It is known that deficiency of lysosomal acid alpha-glucosidase acid maltase leads to progressive generalised myopathy, cardiomyopathy and death in early infancy because of respiratory muscle weakness. Excessive undegradable intracellular glycogen deposition plays a role in the pathogenesis of the disease. Here we report a 3.5 month-old girl presenting with respiratory failure due to pneumonia and hypotonia, who was later diagnosed as Pompe disease

Anahtar Kelimeler

Pompe disease, infancy, hypotonia

Kaynakça

• 1. Pompe JC. Over idiopatische hypertrophie van her hart. Ned Tijdshr Geneeskd 1932;76:304.
• 2. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006;148:671- 6.
• 3. Shapir Y, Roguin N. Echocardiographic findings in Pompe’s disease with left ventricular obstruction. Clin Cardiol 1985;8:181- 5.
• 4. Rees A, Elbl F, Minhas K, Solinger R. Echocardiographic evidence of outflow tract obstruction in Pompe’s disease (glycogen storage disease of the heart) Am J Cardiol 1976;37:1103-6.
• 5. Winkel LP, Hagemans ML, Van Doorn PA, Loonen MC, Hop WJ, Reuser AJ, et al. The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol 2005;252:875- 84.
• 6. Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, et al. Pompe disease diagnosis and management guidelines. Genet Med 2006;8:267-88.
• 7. Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, et al. Recombinant human acid α-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007;68:99-109.
• 8. Hirschhorn R, Reuser AJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver CR, Beaudet A, Sly WS, Valle D, Eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill 2001;135:3389-420.
• 9. Ehlers KH, Hagstrom JW, Lukas DS, Redo SF, Engle MA. Glycogen-storage disease of the myocardium with obstruction to left ventricular outflow. Circulation 1962;25:96-109.
• 10. Hohn AR, Lowe CU, Sokal JE, Lambert EC. Cardiac problems in the glycogenoses with specific reference to Pompe’s disease. Pediatrics 1965;35:313-21.
• 11. Van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe’s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332-40.
• 12. Howell RR, Byrne B, Darras BT, Kishnani P, Nicolino M, van der Ploeg A. Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome. Genet Med 2006;8:289-96.
• 13. Di Rocco M, Buzzi D, Tarò M. Glycogen storage disease type II: clinical overview. Acta Myol 2007;26:42-4